Maternal gene polymorphisms involved in folate metabolism as risk factors for Down syndrome offspring in Southern Brazil

Disease Markers

Volumn 29, Issue 2, 2010, Pages 95-101

  Brandalize, Ana Paula Carneiro ^a,b   Bandinelli, Eliane ^a   Santos, Pollyanna Almeida Dos ^a   Schüler Faccini, Lavínia ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

CBS; Down syndrome; folate; MTR; MTRR; RFC

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5;

ADULT; ALLELE; ARTICLE; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DOWN SYNDROME; FEMALE; FOLATE METABOLISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 78649529195     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.3233/DMA-2010-0731     Document Type: Article

References (35)

1. S.E. Antonarakis, M.B. Petersen, M.G. McInnis, P.A. Adelsberger, A.A. Schinzel, F. Binkert, C. Pangalos, O. Raoul, S.A. Slaugenhaupt and M. Hafez, The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms, Am J Hum Genet 50 (1992), 455-550.
2. L.B. Bailey, New standard for dietary folate intake in pregnant women, Am J Clin Nutr 71 (2000), 1304S-1307S.
3. J.M. Biselli, E.M. GoloniBertollo, B.L. Zampieri, R. Haddad, M.N. Eberlin and E.C. PavarinoBertelli, Genetic polymorphisms involved in folate metabolismand elevated plasma concentrations of homocysteine: maternal risk factors for Down syndrome in Brazil, Genet Mol Res 7 (2008), 33-42.
4. B.C. Blount, M.M. Mack, C.M. Wehr, J.T. MacGregor, R.A. Hiatt, G.Wang, S.N.Wickramasinghe, R.B. Everson and B.N. Ames, Folate deficiency causes uracil misincorporation into humanDNAand chromosome breakage: implications for cancer and neuronal damage, Proc Natl Acad Sci USA 94 (1997), 3290-3295.
5. K. Boduroǧlu, Y. Alanay, B. Koldan and E. Tunçbilek, Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women, Am J Med Genet 127A (2004), 5-10.
6. P. Bosco, R.M. GuéantRodriguez, G. Anello, C. Barone, F. Caraci, A. Romano, C. Romano and J.L. Guéant, Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome, Am J Med Genet 121 (2003), 219-224.
7. A.P.C. Brandalize, E. Bandinelli, P.A. Santos, I. Roisenberg and L. SchullerFaccini, Evaluation of C677T and A1298C Polymorphisms of theMTHFRGene asMaternal Risk Factors for Down Syndrome and Congenital Heart Defects, Am J Med Genet 1267 (2009), 9-17.
8. C.A. Brown, K.Q. McKinney, J.S. Kaufman, R.A. Gravel and R. Rozen, A common polymorphism in the methionine synthase reductase increases risk of premature coronary artery disease, J Cardiov Risk 7 (2000), 197-200.
9. C. Butler, A.J. Knox, J. Bowersox, S. Forbers and D. Paterson, The production of transgenic mice expressing human cysthathionine betasynthase to study Down syndrome, Behav Genet 36 (2006), 429-438.
10. B. ChadefauxVekemans, M. Coudé, F. Muller, J.F. Oury, A. Chabli, J. Jaïs and P. Kamoun, Methylenetetrahydrofolate reductase polymorphism in the etiology of Down syndrome, Pediatr Res 51 (2002), 766-767.
11. A. Chango, N. FillonEmery, C.Mircher, H. Bléhaut, D. Lambert, B. Herbeth, S.J. James, M.O. Réthoré and J.P. Nicolas, No association between common polymorphisms in genes of folate and homocysteine metabolism and the risk of Down's syndrome among French mothers, Br J Nutr 94 (2005), 166-169.
12. F. Coppedè, G. Marini, S. Bargagna, L. Stuppia, F.Minichilli, I. Fontana, R. Colognato, G. Astrea, G. Palka and L.Migliore, Folate gene polymorphisms and the risk of Down syndrome pregnancies in young Italian women, Am J Med Genet 140 (2006), 1083-1091.
13. F. Coppedè, The complex relationship between folate/homocysteine metabolism and risk ofDown syndrome, Mut Res 682 (2009), 54-70.
14. P. Goyette, J.S. Sumner, R. Milos, A.M. Duncan, D.S. Rosenblatt, R.G.Matthews and R. Rozen, Humanmethylenetetrahydrofolate reductase: isolation of cDNA,mapping andmutation identification, Nat Genet 7 (1994), 195-200.
15. C.A.Hobbs, S.L. Sherman, P.Yi, S.E.Hopkins, C.P. Torfs,R.J. Hine, M. Pogribna, R. Rosen and S.J. James, Polymorphisms in genes involved in folate metabolism as maternal risk factors for down syndrome, Am J Hum Genet 67 (2000), 623-630.
16. C.A. Hobbs, M.A. Cleves, R.M. Lauer, S. Melnyk, Y. Lu, S. Malik and M.A. Cleves, Preferential transmission of the MTHFR 677 T allele to infants with Down syndrome: implications for a survival advantage, Am J Med Genet 113 (2002), 9-14.
17. S.J. James, M. Pogribna, I.P. Pogribny, S. Melnyk, R.J. Hine, J.B. Gibson, P. Yi, D.L Tafoya, D.H. Swenson, V.L. Wilson andD.W.Gaylor, Abnormal folatemetabolismandmutation in themethylenetetrahydrofolate reductase genemay bematernal risk factors for Down syndrome, Am J Clin Nutr 70 (1999), 495-501.
18. S.J. James, Maternal metabolic phenotype and risk of down syndrome: beyond Genetics, Am J Med Genet 127 (2004), 1-4.
19. L.A. Kluijtmans, L.P. Van Der Heuvel, G.H. Boers, P. Frosst, E.M. Stevens, B.A. Van Oost, F.J. Trijbels and R.I. Rozen, Molecular genetic analysis in mild hyperhomocysteinemia: A common mutation in methylenetetrahydrofolate reductase gene is a genetic risk for cardiovascular disease, Am J Hum Genet 58 (1996), 35-41.
20. E. Krivchenia, C.A. Huether, L.D. Edmonds, D.S.May and S. Guckenberger, Comparative epidemiology ofDown syndrome in two United States populations, Am J Epidemiol 137 (1993), 815-828.
21. K.M. Lahiri and Jr. Nurnberger, A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies, Nucleic Acids Res 19 (1991), 5444.
22. D. Leclerc, E. Campeau, P. Goyette, C.E. Adjalla, B. Christensen, M. Ross, P. Eydoux, D.S. Rosenblatt, R. Rozen and R.A. Gravel, Human methionine synthase: cDNA cloning and identification ofmutations in patients of the cblG complementation group of folate/cobalamin disorders, Hum Mol Genet 5 (1996), 1867-1874.
23. D. Leclerc, A. Wilson, R. Dumas, C. Gafuik, D. Song, D. Watkins, H.H. Heng, J.M. Rommens, S.W. Scherer, D.S. Rosenblatt and R.A. Gravel, Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria, Proc Natl Acad Sci USA 95 (1998), 3059-3064.
24. M.L. MartínezFr ías, B. Pérez, L.R. Desviat, M. Castro, F. Leal, L. Rodríguez, E. Mansilla, M.L. MartínezFern ández, E. Bermejo, E. RodríguezPinilla, D. Prieto and M. Ugarte, Maternal polymorphisms 677CT and 1298AC of MTHFR, and 66AG MTRR genes: is there any relationship between polymorphisms of the folate pathway, maternal homocysteine levels, and the risk for having a child with Down syndrome? Am J Med Genet 140 (2006), 987-997.
25. N.A.Meguid, A.A. Dardir, M. Khass, L.E. Hossieny, A. Ezzat andM.K. El Awady,MTHFR genetic polymorphisms as a risk factor in Egyptian mothers with Down syndrome children, Dis Markers 24 (2008), 19-26.
26. T.T Nguyen, D.L. Dyer, D.D. Dunning, S.A. Rubin, K.E. Grant and H.M. Said, Human intestinal folate transport cloning, expression and distribution of complementary RNA, Gastroenterology 112 (1997), 783-791.
27. V.B. O'Leary, A. ParleMcDermott, A.M.Molloy, P.N. Kirke, Z. Johnson, M. Conley, J.M. Scott and J.L. Mills, MTRR and MTHFR polymorphism: Link to Down syndrome? Am J Med Genet 107 (2002), 151-155.
28. E. Pozzi, P. Vergani, L. Dalprà, R. Combi, D. Silvestri, F. Crosti, M. Dell'Orto and M.G. Valsecchi, Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome, Am J Obstetr Gynecol 6 (2009), 636.e1-e6.
29. A.K. Rai, S. Singh, S. Mentha, A. Kumar, L.K. Pandey and R. Raman, MTHFR C677T and A1298C polymorphisms are risk factors for Down's Syndrome in Indian mothers, J Hum Genet 51 (2006), 278-283.
30. I. Scala, B. Granese, M. Sellitto, S. Salome, A. Sammartino, A. Pepe, P. Mastoiacovo, G. Sebastio and G. Andria, Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down Syndrome offspring, Genet Med 8 (2006), 409-416.
31. L.R. Silva, N. Vergani, L.C. Galdieri, M.P.E. Porto, S.B. Longhitano, D. Brunoni, V. D'Almeida and A.B. Alvarez Perez, Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil, Am J Med Genet 135 (2005), 263-267.
32. L. Stuppia, V. Gatta, A.R. Gaspari, I. Antonucci, E. Morizio, G. Calabrese and G.Palka, C677T mutation in the 5,10MTHFR gene and risk of Down syndrome in Italy, Eur J Hum Genet 10 (2002), 388-390.
33. N.M. Van der Put, E.F. van der Molen, L.A. Kluijitmans, S.G. Heil, J.M. Trijbels, T.K. Eskes, D. Van OppenraaijEmmerzaal, R. Banerjee and H.J. Blom, Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neuraltube defects and vascular disease, QJM 90 (1997), 511-517.
34. W.C. Winkelmayer, C. Eberle, G. SunderPlassmann and M. Fodinger, Effects of the glutamate carboxypeptidase II (GCP2 1561C>T) and reduced folate carrier (RFC1 80G>A) allelic variants on folate and total homocysteine levels in kidney transplant patients, Kidney Int 63 (2003), 2280-2285.
35. E. Zintzaras, Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta analysis, J Hum Genet 52 (2007), 943-953.